Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction

Journal of the American College of Cardiology

Volumn 71, Issue 4, 2018, Pages 429-438

  Menasché, Philippe ^a,b   Vanneaux, Valérie ^c,d   Hagège, Albert ^a,b   Bel, Alain ^a   Cholley, Bernard ^a,b   Parouchev, Alexandre ^c,d   Cacciapuoti, Isabelle ^c,d   Al Daccak, Reem ^d   Benhamouda, Nadine ^a   Blons, Hélène ^a   Agbulut, Onnik ^e   Tosca, Lucie ^f   Trouvin, Jean Hugues ^b,f   Fabreguettes, Jean Roch ^f   Bellamy, Valérie ^a   Charron, Dominique ^b,c   Tartour, Eric ^a,b   Tachdjian, Gérard ^f   Desnos, Michel ^a,b   Larghero, Jérôme ^b,c,d  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d INSERM   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

cardiovascular progenitor cells; embryonic stem cells; heart failure; tissue engineering

Indexed keywords

ANTIBODY; FIBRIN; FLUORODEOXYGLUCOSE F 18;

AGED; ALLOIMMUNIZATION; ARTICLE; BLOOD PATCH; CARDIAC MUSCLE CELL; CAUSE OF DEATH; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS SURGERY; DISEASE SEVERITY; DONOR; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; MALE; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; CORONARY ARTERY BYPASS GRAFT; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; MORTALITY; PROCEDURES; SURVIVAL RATE; TRANSPLANTATION; TREATMENT OUTCOME;

AGED; COHORT STUDIES; CORONARY ARTERY BYPASS; FEASIBILITY STUDIES; FEMALE; HUMAN EMBRYONIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 85041908366     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.11.047     Document Type: Article

References (37)

1. Chugh, A.R., Beache, G.M., Loughran, J.H., et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 126 Suppl 1 (2012), S54–S64.
2. Makkar, R.R., Smith, R.R., Cheng, K., et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379 (2012), 895–904.
3. Lundy, S.D., Gantz, J.A., Pagan, C.M., Filice, D., Laflamme, M.A., Pluripotent stem cell derived cardiomyocytes for cardiac repair. Curr Treat Options Cardiovasc Med, 16, 2014, 319.
4. Roche, E.T., Hastings, C.L., Lewin, S.A., et al. Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart. Biomaterials 35 (2014), 6850–6858.
5. Bellamy, Vanneaux, V., Bel, A., et al. Long term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold. J Heart Lung Transplant 34 (2015), 1198–1207.
6. Menasché, P., Vanneaux, V., Hagège, A., et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur Heart J 36 (2015), 2011–2017.
7. Menasché, P., Vanneaux, V., Fabreguettes, J.R., et al. Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. Eur Heart J 36 (2015), 743–750.
8. Oskouei, B.N., Lamirault, G., Joseph, C., et al. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair. Stem Cells Transl Med 1 (2012), 116–124.
9. Fernandes, S., Chong, J.J., Paige, S.L., et al. Comparison of human embryonic stem cell-derived cardiomyocytes, cardiovascular progenitors, and bone marrow mononuclear cells for cardiac repair. Stem Cell Reports 5 (2015), 753–762.
10. Van Berlo, J.H., Kanisicak, O., Maillet, M., et al. c-Kit+ cells minimally contribute cardiomyocytes to the heart. Nature 509 (2014), 337–341.
11. Sharma, S., Mishra, R., Bigham, G.E., et al. A deep proteome analysis identifies the complete secretome as the functional unit of human cardiac progenitor cells. Circ Res 120 (2017), 816–834.
12. Priest, C.A., Manley, N.C., Denham, J., Wirth, E.D. 3rd, Lebkowski, J.S., Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury. Regen Med 10 (2015), 939–958.
13. Schwartz, S.D., Regillo, C.D., Lam, B.L., et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 385 (2015), 509–516.
14. Agulnick, A.D., Ambruzs, D.M., Moorman, M.A., et al. Insulin-producing endocrine cells differentiated in vitro from human embryonic stem cells function in macroencapsulation devices in vivo. Stem Cells Transl Med 4 (2015), 1214–1222.
15. Moretti, A., Caron, L., Nakano, A., et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127 (2006), 1151–1165.
16. Hamdi, H., Furuta, A., Bellamy, V., et al. Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann Thorac Surg 87 (2009), 1196–1203.
17. Vallée, J.-P., Hauwel, M., Lepetit-Coiffé, M., et al. Embryonic stem cell-based cardiopatches improve cardiac function in infarcted rats. Stem Cells Transl Med 1 (2012), 248–260.
18. Tulloch, N.L., Muskheli, V., Razumova, M.V., et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 109 (2011), 47–59.
19. Schwartz, S.D., Hubschman, J.P., Heilwell, G., et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379 (2012), 713–720.
20. Hentze, H., Graichen, R., Colman, A., Cell therapy and the safety of embryonic stem cell-derived grafts. Trends Biotechnol 25 (2007), 24–32.
21. Mummery, C.L., Zhang, J., Ng, E.S., Elliott, D.A., Elefanty, A.G., Kamp, T.J., Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 11 (2012), 344–358.
22. Trivanović, D., Jauković, A., Popović, B., et al. Mesenchymal stem cells of different origin: comparative evaluation of proliferative capacity, telomere length and pluripotency marker expression. Life Sci 141 (2015), 61–73.
23. Beeravolu, N., Khan, I., McKee, C., et al. Isolation and comparative analysis of potential stem/progenitor cells from different regions of human umbilical cord. Stem Cell Res 16 (2016), 696–711.
24. Hovatta, O., Jaconi, M., Töhönen, V., et al. A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes. PLoS One, 5, 2010, e10263.
25. Chong, J.J., Yang, X., Don, C.W., et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510 (2014), 273–277.
26. Terajima, Y., Shimizu, T., Tsuruyama, S., et al. Autologous skeletal myoblast sheet therapy for porcine myocardial infarction without increasing risk of arrhythmia. Cell Med 6 (2013), 99–109.
27. Chen, H.S., Kim, C., Mercola, M., Electrophysiological challenges of cell-based myocardial repair. Circulation 120 (2009), 2496–2508.
28. Al-Daccak, R., Charron, D., Allogenic benefit in stem cell therapy: cardiac repair and regeneration. Tissue Antigens 86 (2015), 155–162.
29. Boukouaci, W., Lauden, L., Siewiera, J., et al. Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence. Cardiovasc Res 104 (2014), 290–302.
30. Hocine, H.R., Costa, H.E., Dam, N., et al. Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells. Sci Rep, 7, 2017, 41125.
31. Malliaras, K., Li, T.S., Luthringer, D., Terrovitis, J., et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation 125 (2012), 100–112.
32. Kandala, J., Upadhyay, G.A., Pokushalov, E., Wu, S., Drachman, D.E., Singh, J.P., Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy. Am J Cardiol 112 (2013), 217–225.
33. Garbern, J.C., Lee, R.T., Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell 12 (2013), 689–698.
34. Kervadec, A., Bellamy, V., Harane N El, et al. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. J. Heart Lung Transplant 35 (2016), 795–807.
35. Tao, L., Bei, Y., Zhou, Y., Xiao, J., Li, X., Non-coding RNAs in cardiac regeneration. Oncotarget 6 (2015), 42613–42622.
36. Funakoshi, S., Miki, K., Takaki, T., et al. Enhanced engraftment, proliferation and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci Rep, 6, 2016, 19111.
37. Foldes, C., Terzic, A., Metabolic determinants of embryonic development and stem cell fate. Reprod Fertil Dev 27 (2014), 82–88.